Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3010-3020

  Beck, William T ^a,q   Grogan, Thomas M ^b,r   Willman, Cheryl L ^c   Cordon Cardo, Carlos ^d   Parham, David M ^a,s   Kuttesch, John F ^a,e   Andreeff, Michael ^e   Bates, Susan E ^f   Berard, Costan W ^a   Boyett, James M ^a   Brophy, Nathalie A ^g   Broxterman, Henk J ^h   Chan, Helen S L ⁱ   Dalton, William S ^b   Dietel, Manfred ^j   Fojo, Antonio T ^f   Gascoyne, Randy D ^o   Head, David ^a   Houghton, Peter J ^a   Srivastava, Deo Kumar ^a   Lehnert, Manfred ^p   Leith, Catherine P ^c   Paietta, Elisabeth ^k   Pavelic, Zlatko P ^l   Rimsza, Lisa ^b   Roninson, Igor B ^m   Sikic, Branimir I ^g   Twentyman, Peter R ⁿ   Warnke, Roger ^g   Weinstein, Ronald ^b   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j HUMBOLDT UNIVERSITY   (Germany)

^k ALBERT EINSTEIN CANCER CENTER   (United States)

^l UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^m UNIVERSITY OF ILLINOIS   (United States)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p University of Illinois at Chicago ^*  (Switzerland)

^q UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^r UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^s UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CHROMOGENIC SUBSTRATE; DOXORUBICIN; EPITOPE; GLYCOPROTEIN P; REAGENT;

ARTICLE; CALIBRATION; CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPHOMA; MULTIDRUG RESISTANCE; MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TECHNIQUE; TUMOR;

DRUG RESISTANCE, MULTIPLE; EVALUATION STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KB CELLS; NEOPLASMS; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED;

EID: 8944261743     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S-L., Gazdar, A., Pirker, R , Green, A., Crist, W , Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81. 116-124, 1989.
2. Fojo, A. T., Ueda, K , Slamon, D. J., Poplack, D G., Gottesman, M M., and Pastan, I Expression of multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad Sci. USA, 84: 265-269, 1987.
3. Herzog, C E., Trepel, J B., Mickley, L. A., Bates, S. E , and Fojo, A. T. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines. J. Natl. Cancer Inst., 84: 711-716, 1992.
4. Brophy, N. A., Marie, J. P., Rojas, V. A., Warnke, R. A., McFall, P. J., Smith, S. D., and Sikic, B. I. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. Leukemia (Baltimore), 8: 327-335, 1994.
5. Chan, H. S L , DeBoer, G., Haddad, G , Gallie, B. L., and Ling, V. Multidrug resistance in pediatric malignancies. Hematol Oncol. Clin. N. Am., 9: 275-318, 1995.
6. van der Heyden, S., Gheuens, E , De Bruijn, E., Van Oosterom, A., and Maes, R. P-glycoprotein: clinical significance and methods of analysis. Crit. Rev. Clin. Lab. Sci , 32: 221-264, 1995.
7. Lum, B. L., Fisher, G A , Brophy, N. A., Yahanda, A. M., Adler, K. M., Kaubisch, S , Halsey, J., and Sikic, B. I Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations. Cancer (Phila.), 72. 3502-3514, 1993.
8. Raderer, M., and Scheithauer, W. Clinical trials of agents that reverse multidrug resistance. A literature review Cancer (Phila.), 72: 3553-3563, 1993.
9. Fisher, G A., and Sikic, B. I Clincial studies with modulators of multidrug resistance. Hematol. Oncol. Clin. N. Am., 9: 363-382, 1995.
10. Sikic, B. I. Modulation of multidrug resistance: at the threshold. J. Clin. Oncol., 11: 1629-1635, 1993.
11. Arceci, R. J. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood, 81: 2215-2222, 1993.
12. Kaye, S B. P-glycoprotein (P-gp) and drug resistance: time for reappraisal? Br. J. Cancer, 67: 641-643, 1993.
13. Murren, J. R., and Hait, W. N. Why haven't we cured multidrug resistant tumors? Oncol. Res., 4: 1-6, 1992.
14. Bates, S. E., Meadows, B., Goldspiel, B R., Denicoff, A., Le, T. B., Tucker, E., Steinberg, S., and Elwood, L. J. A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer. Cancer Chemother. Pharmacol., 35: 457-463, 1995.
15. Leith, C. P., Chen, I M., Kopecky, K. J., Appelbaum, F. R., Head, D R., Godwin, J. E , Weick, J K , and Willman, C. L. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry identification of discordant MDR-/efflux+ and MDR+/efflux- cases. Blood, 86: 2329-2342, 1995.
16. Chan, H. S. L., Thorner, P., Haddad, G., and Ling, V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol., 8: 689-704, 1990.
17. Chan, H. S. L., Haddad, G , Thorner, P. S., DeBoer, G., Lin, Y. P , Ondrusek, N., Yeger, H., and Ling, V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl J Med , 325: 1608-1614, 1991.
18. Pirker, R., Wallner, J., Geissler, K , Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., Ludwig, H., and Lechner, K. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst., 83. 708-712, 1991.
19. Marie, J. P., Zittoun, R., and Sikic, B. I. Multidrug resistance (MDR1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity Blood, 78. 586-592, 1991.
20. Kuttesch, J. F., Parham, D. M., Luo, X , Meyer, W. H., Bowman, L , Shapiro, D N., Pappo, A. S , Crist, W M., Beck, W. T., and Houghton, P. J P-glycoprotein expression at diagnosis does not correlate with response or outcome in childhood rhabdomyosarcoma. J Clin. Oncol , 14: 886-900, 1996.
21. Thiebaut, F , Tsuruo, T , Hamada, H., Gottesman, M. M., Pastan, I , and Willingham, M C Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem., 37: 159-164, 1989
22. Rao, V. V., Anthony, D. C., and Piwnica-Worms, D. MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase Cancer Res., 54: 1536-1541, 1994.
23. Hamblin, T. J. Meeting report. 1st international conference on reversal of multidrug resistance in cancer Leuk. Res., 19: 427-428, 1995.
24. Tóth, K., Vaughan, M. M., Slocum, H. K., Arredondo, M. A., Takita, H., Baker, R. M., and Rustum, Y M New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. Am. J Pathol., 144. 227-236, 1994
25. Beck, W. T , Mueller, T. J , and Tanzer, L. R. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts Cancer Res., 39: 2070-2076, 1979.
26. Akiyama, S-I., Fojo, A., Hanover, J. A., Pastan, I., and Gottesman, M. M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs Somatic Cell Mol Genet., 11: 117-126, 1985.
27. Dalton, W. S , Durie, B G. M., Alterts, D. S., Gerlach, J. M., and Cress, A. E. Characterization of a new drug resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res., 46: 5125-5130, 1986.
28. Shen, D-W., Cardarelli, C , Hwang, J., Cornwell, M , Richert, N., Ishii, S , Pastan, I., and Gottesman, M. M. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J. Biol. Chem., 261: 7726-7770, 1986.
29. Arceci, R. J., Stieglitz, K., Bras, J., Schinkel, A., Baas, F., and Croop, J Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res., 53: 310-317, 1993.
30. Kartner, N., Evernden-Porelle, D., Bradley, G., and Ling, V. Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature (Lond ), 316. 820-823, 1985.
31. Scheper, R. J., Bulte, J. W. M., Brakke, J. G. P., Quak, J. J., van der Schoot, E., Balm, A. J. M., Meijer, C. J. L. M , Broxterman, H J., Kuiper, C. M., Lankelma, J., and Pinedo, H. M. Monoclonal antibody JSB1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug resistance. Int. J Cancer, 42: 389-394, 1988.
32. Mechetner, E. B , and Roninson, I. B. Efficient inhibition of P-glycoprotein-mediated resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. USA, 89. 5824-5828, 1992.
33. Hamada, H , and Tsuruo, T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 83: 7785-7789, 1986.
34. r 170,000 P-glycoproteins in multidrug resistant human tumor cells. Cancer Res., 49: 3209-3214, 1989.
35. Rimsza, L., Weinstein, R., Rangel, C., and Grogan, T. Optimization of P-glycoprotein detection in formalin fixed paraffin embedded tissues utilizing antigen retrieval methods. Anticancer Drugs, 5: 11-12, 1994
36. Grogan, T., Dalton, W., Rybski, J , Spier, C , Meltzer, P., Richter, L , Gleason, M., Pindur, J., Cline, A., Scheper, R., Tsuruo, T., and Salmon S. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies Lab. Invest., 63: 815-824, 1990.
37. Chan, H. S. L., Bradley, G., Thorner, P., Haddad, G., Gallie, B L., and Ling, V. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell line. Lab. Invest., 59: 870-875, 1988.
38. Cordell, J. L., Falini, B , Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., and Mason, D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal and anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem., 32: 219-229, 1984.
39. Haddad, G., Thorner, P. S., Bradley, G., Dalton, W. S., Ling, V., Chan, H. S. L. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow. Lab. Invest., 71: 595-603, 1994.
40. Pavelic, Z. P., Sever, Z., Fontaine, R., Baker, V. V., Reising, J., Denton, D. M., Pavelic, L. J., and Khalily, M. Detection of P-glycoprotein with JSB-1 monoclonal antibody in B-5 fixed and paraffin-embedded cell lines and tissues. Sel. Cancer Ther , 7: 49-58, 1991.
41. Giorno, R. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn. Immunol., 2: 161-166, 1984.
42. Gown, A. M., de Wever, N., and Battifora, H. Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl. Immunohistochem., 1. 256-266, 1993.
43. Paietta, E., Andersen, J., Racevskis, J., Gallagher, R , Bennett, J. Yunis, J., Cassileth, P., and Wiernik, P H. Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses. Leukemia (Baltimore), 8: 968-973, 1994
44. Broxterman, H. J., Feller, N., Kuiper, C. M., Boven, E., Versantvoort, C. H M., Teerlink, T., Pinedo, H. M., and Lankelma, J Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts. Int. J. Cancer, 61: 880-886, 1995
45. Feller, N., Juiper, C. M., Lankelma, J , Ruhdal, J. K., Scheper, R. J., Pinedo, H. M., and Broxterman, H. J Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumor cells by flow cytometry. Br. J. Cancer, 72: 543-549, 1995
46. Lee, J. S , Paull, K., Alvarez, M., Hose, C., Monks, A., Grever, M , Fojo, A. T., and Bates, S. E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute Drug Screen. Mol. Pharmacol., 46: 627-638, 1994
47. Chomczynski, P., and Sacchi, N Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
48. Murphy, L. D., Herzog, C. E., Rudick, J. R., Fojo, A. T., and Bates, S. E. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry, 29: 10351-10356, 1990.
49. Futscher, B. W., Blake, L. L., Gerlach, J. M., Grogan, T. M , and Dalton, W. S. Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Anal. Biochem., 213: 414-421, 1993.
50. Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J S., Andrulis, I. L , Gazdar, A F., Willman, C. L., Griffith, B., von Hoff, D. D., and Roninson, I. B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87: 7160-7164, 1990.
51. Dietel, M , Arps, H., Lage, H., and Niendorf, A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res., 50. 6100-6106, 1990.
52. Dietel, M What's new in cytostatic drug resistance and pathology. Pathol. Res. Pract , 187: 892-905, 1991.
53. Dietel, M., Herzig, I , Reymann, A., Brandt, I., Schafer, B., Bunge, A., Heidebrecht, H. J., and Seidel, A. Secondary combined resistance to the multidrug resistance reversing activity of cyclosporin A in the cell line F4-6RADR-CsA. Cancer Res Clin. Oncol., 120. 263-271, 1994
54. Holm, P. S., Scanlon, K. J , and Dietel, M. Reversion of multidrug resistance in the p-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of hammerhead ribozyme. Br. J Cancer, 70: 239-243, 1994.
55. Chaudhary, P. M., Mechetner, E. B., and Roninson, I. B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 11: 2735-2739, 1992.
56. Drach, D., Shourong, Z., Drach, J., Mahadevia, R., Gattringer, C., Huber, H., and Andreeff, M Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood, 80: 2729-2734, 1992.
57. Klimecki, W. T., Futscher, B. W. Grogan, T. M., and Dalton, W. S. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83 2451-2458, 1994.
58. Willman, C. L. Flow cytometric analysis of hematologic specimens. In: D. M. Knowles (ed.), Neoplastic Hematopathology, p. 169. Baltimore, MD: Williams & Wilkins, 1992.
59. Taylor, J. J., and Heasman, P. A. Control genes for reverse transcriptase/polymerase chain reaction (RT-PCR). Br. J Haematol., 86: 444-445, 1994.
60. Cole, S P C, Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E U., Duncan, A. M. V., and Deeley, R. G Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
61. Grant, C. R , Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P C , Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54. 357-361, 1994.
62. Kruh, G. D., Chan, A., Myers, K., Gaughan, K., Miki, T., and Aaronson, S. A. Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res., 54: 1649-1652, 1994
63. Schuurhuis, G. J , Broxterman, H. J , Ossenkoppele, G. J., Baak, J P. A., Eekman, C. A. Kuiper, C. M., Feller, N., van Heijningen, T. H. M., Klumper, E., Pieters, R., Lankelma, J., and Pinedo, H M. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia Clin Cancer Res , 1: 81-93, 1995.
64. Scheffer, G. L., Wijngaard, P L. J., Flens, M. J , Izquierdo, M. A., Slovak, M. L., Pinedo, H. M., Meijer, C. J L M., Clevers, H. C , and Scheper, R. J. The drug resistance-related protein LRP is the human major vault protein Nat. Med., 1: 578-582, 1995.
65. Izquierdo, M. A , van der Zee, A G. J , Vermorken, J. B., van der Valk, P., Belien, J A M , Giaccone, G , Scheffer, G L., Flens, M. J., Pinedo, H. M., Kenemans, P., Meijer, C. J L. M , de Vries, E. G. E., and Scheper, R. J Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovanan carcinoma. J. Natl Cancer Inst , 87: 1230-1237, 1995.
66. Beck, W. T., Danks, M K., Wolverton, J S., Chen, M., Granzen, B., Kim, R., and Suttle, D. P. Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II. Adv. Pharmacol., 29B: 145-169, 1994